Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis

Clinical Reviews in Allergy and Immunology

Volumn 42, Issue 2, 2012, Pages 131-134

  Pontikaki, Irene ^a   Shahi, Edit ^a   Frasin, Lucretia Adina ^b   Gianotti, Raffaele ^a   Gelmetti, Carlo ^a   Gerloni, Valeria ^a   Meroni, Pier Luigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Adverse events; Juvenile idiopathic arthritis; Skin manifestations; TNF inhibitors

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VITAMIN D;

ACANTHOSIS; ADOLESCENT; ADULT; CASE REPORT; CORTICOSTEROID THERAPY; CROHN DISEASE; CUTANEOUS LEUCOCYTOCLASTIC VASCULITIS; DERMATITIS; DERMATOLOGICAL PROCEDURE; DESQUAMATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTHELIUM CELL; ERYTHEMA; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LICHENOID ERUPTION; MALE; MONOTHERAPY; PARAKERATOSIS; PSORIASIS; PUNCH BIOPSY; REMISSION; REVIEW; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; TREATMENT DURATION; VASCULITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, JUVENILE RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOTHERAPY; LICHEN PLANUS; MALE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; YOUNG ADULT;

EID: 84862856646     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-011-8262-2     Document Type: Review

References (20)

1. Mease P (2004) TNF-α therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 63:755-758 (Pubitemid 38850443)
2. Winterfield LS, Menter A, Gordon K, Gottlieb A (2005) Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis 64(Suppl 2):87-90
3. Sfikakis PP, Kollias G (2003) Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15:380-386 (Pubitemid 36774248)
4. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoim-mune diseases induced by TNF-targeted therapies: analysis of233 cases. Medicine (Baltimore) 86:242-251 (Pubitemid 47067483)
5. Cohen JD, Bournerias I, Buffard V, Paufler A, Chevalier X, Bagot M, Claudepierre P (2007) Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. J Rheumatol 34:380-385
6. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 52:2513-2518 (Pubitemid 41117439)
7. Saint Marcoux B, De Bandt M, CRI (Club Rhumatismes et Inflammation) (2006) Vasculitides indiced by TNFalpha antago-nists: a study in 39 patients in France. Joint Bone Spine 73:710-713
8. Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euller-Ziegler L (2007) New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effectα. J Rheumatol 34:434-437
9. Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, Ständer E, Maass U, Lee H, Sterry W, Burmester GR (2006) New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 65:405-407 (Pubitemid 43268235)
10. Carter JD, Gerard HC, Hudson AP (2008) Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis 67:1181-1183
11. Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H (2007) Psoriasiform and pustular eruption induced by infliximab. J Dermatol 34:468-472 (Pubitemid 46956592)
12. Collamer AN, Guerrero KT, Henning JS, Battafarano DF (2008) Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 59:996-1001 (Pubitemid 351990997)
13. Kolarz B, Targoαska-Stepniak B, Darmochwaα-Kolarz D, Majdan M (2007) Autoimmune aspects of treatment with TNF-alpha inhibitors. Postepy Hig Med Dosw (Online) 61:478-484, Review. Polish
14. Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ (2006) Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 54:1003-1012
15. Aslanidis S, Pyrpasopoulou A, Douma S, Triantafyllou A (2008) Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine. Clin Rheumatol 27:377-380
16. De Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP (2007) Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol 143:223-231 (Pubitemid 46294587)
17. Davaine AC, Saraux A, Prigent S, Kupfer-Bessaguet I, Roswag D, Plantin P, Schoenlaub P, Talarmin F, Zagnoli A, Misery L (2008) Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study. J Eur Acad Dermatol Venereol 22:1471-1477
18. Beuthien W, MellinghoffHU, von Kempis J (2004) Skin reaction to adalimumab. Arthritis Rheum 50:1690-1692 (Pubitemid 38608093)
19. Fiorentino DF (2007) The Yin and Yang of TNF-{alpha} inhibition. Arch Dermatol 143:233-236
20. Calabrese L (2006) The yin and yang of tumor necrosis factor inhibitors. Cleve Clin J Med 73:251-256